Lisa Donofrio, MD

Yale University School of Medicine
Department of Dermatology
New Haven, CT
USA 06511
Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial